Aspire Private Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Aspire Private Capital's SYNH Position: Q1 2022 in Review
Aspire Private Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 5,946 shares — an estimated $611K sold.
Aspire Private Capital first reported a position in SYNH in Q3 2021 and held it in 2 quarters. The position peaked at $611K in Q4 2021. 365 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.
- Aspire Private Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- Aspire Private Capital sold 5,946 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $611K.
- Aspire Private Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 2 quarters.
- Aspire Private Capital's Syneos Health, Inc. Class A Common Stock position peaked at $611K in Q4 2021.
- 365 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.
Based on Aspire Private Capital's 13F filing for Q1 2022, filed 10 May 2022.